AB Capital's Q2FY24 Financial Performance Review

In this financial performance review, we delve into the results of AB Capital for the second quarter of fiscal year 2024 and analyze key metrics, including revenue, expenses, net profit, and margin.

 

ParticularsQ2FY23YoY (% change)Q1FY24QoQ (% change)Q2FY24
Total Income (₹crs.)6,83313.137,0519.637,730
Total Expenses (₹crs.)6,2398.566,2039.196,773
Net Profit (₹crs.)47951.156658.87724
Margin (%)7.012.369.43-0.079.37

 

REVENUE: 
AB Capital reported a total income of ₹7,730 crores in Q2FY24, demonstrating a substantial increase of 9.63% compared to the preceding quarter. On a year-on-year (YoY) basis, the company's revenue exhibited robust growth, with a 13.13% increase from ₹6,833 crores in Q2FY23.

 

EXPENSES: 
Total expenses for Q2FY24 amounted to ₹6,773 crores, marking a 9.19% increase compared to the expenses in the preceding quarter. On a YoY basis, expenses also increased by 8.56% from ₹6,239 crores in Q2FY23.

 

NET PROFIT: 
AB Capital reported a net profit of ₹724 crores, reflecting an 8.87% increase compared to the net profit of ₹665 crores in the preceding quarter. On a YoY basis, the net profit showed significant growth, with an impressive increase of 51.15% from ₹479 crores in Q2FY23.

 

MARGINS: 
AB Capital's margin in Q2FY24 was 9.37%, a slight decline compared to the margin of 9.43% in the preceding quarter, Q1FY24. On a YoY basis, the margin demonstrated a positive trend, increasing from 7.01% in Q2FY23 to 9.37%.

 

In conclusion, AB Capital's financial performance in the second quarter of fiscal year 2024 reflects a healthy increase in revenue, net profit, and margins. The company has effectively managed expenses while boosting its income, leading to strong YoY growth. These results indicate a positive outlook for AB Capital.

 

Stay tuned for more updates on upcoming financial performances.

Top stories
Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read . 02 Aug 2024 . 12:45 PM

Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read . 02 Aug 2024 . 12:41 PM

Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read . 02 Aug 2024 . 12:36 PM

Related Blogs
blog-logo

Share Market

blog-logo

10 mins read . 09 Dec 2024

What is the Bombay Stock Exchange?

  • 0 people read
blog-logo

Share Market

blog-logo

13 mins read . 09 Dec 2024

Stocks Under 5 Rupees in India

  • 0 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions